Effect of vaping on past-year smoking cessation success of Australians in 2019-evidence from a national survey.


Journal

Addiction (Abingdon, England)
ISSN: 1360-0443
Titre abrégé: Addiction
Pays: England
ID NLM: 9304118

Informations de publication

Date de publication:
08 2022
Historique:
received: 03 12 2021
accepted: 28 03 2022
pubmed: 12 4 2022
medline: 7 7 2022
entrez: 11 4 2022
Statut: ppublish

Résumé

Previous analyses of the effect of e-cigarettes on real world smoking cessation success have mainly been based on surveys undertaken in the United States and United Kingdom, where nicotine e-cigarettes can be readily obtained. In Australia, regulations have made obtaining e-cigarettes containing nicotine difficult. The effectiveness of e-cigarette use as a smoking cessation aid in Australia might therefore be lower than survey-based estimates published to date. This study aimed to estimate the effect of using e-cigarettes for a smoking cessation attempt on past-year smoking cessation success in Australia. Multivariable logistic regression models for past-year smoking cessation success. Respondents to the 2019 wave of Australia's National Drug Strategy Household Survey who made a smoking cessation attempt in the 12 months leading up to the survey. Past-year smoking cessation success was assumed if a smoking cessation attempt resulted in abstinence of more than a month at the time of the survey. In 2019, Australians who attempted to quit smoking using e-cigarettes achieved greater success than smokers attempting to quit without e-cigarettes [adjusted odds ratio (aOR) = 1.68; 95% confidence interval (CI) = 1.09-2.60]. If people who only tried e-cigarettes once or twice are considered not to have used e-cigarettes, the estimated effect was slightly stronger (aOR = 1.98; 95% CI = 1.27-3.10). Also, the estimated odds ratio was higher among vapers who acquired their e-cigarettes from overseas websites (aOR = 2.24; 95% CI = 1.02-4.93). Use of e-cigarettes for a smoking cessation attempt appears to be associated with greater success among Australians who attempted to quit tobacco in 2019 compared with Australians attempting to quit without e-cigarettes, after adjusting for confounding effects.

Sections du résumé

BACKGROUND AND AIMS
Previous analyses of the effect of e-cigarettes on real world smoking cessation success have mainly been based on surveys undertaken in the United States and United Kingdom, where nicotine e-cigarettes can be readily obtained. In Australia, regulations have made obtaining e-cigarettes containing nicotine difficult. The effectiveness of e-cigarette use as a smoking cessation aid in Australia might therefore be lower than survey-based estimates published to date. This study aimed to estimate the effect of using e-cigarettes for a smoking cessation attempt on past-year smoking cessation success in Australia.
DESIGN
Multivariable logistic regression models for past-year smoking cessation success.
SETTING AND PARTICIPANTS
Respondents to the 2019 wave of Australia's National Drug Strategy Household Survey who made a smoking cessation attempt in the 12 months leading up to the survey.
MEASUREMENTS
Past-year smoking cessation success was assumed if a smoking cessation attempt resulted in abstinence of more than a month at the time of the survey.
FINDINGS
In 2019, Australians who attempted to quit smoking using e-cigarettes achieved greater success than smokers attempting to quit without e-cigarettes [adjusted odds ratio (aOR) = 1.68; 95% confidence interval (CI) = 1.09-2.60]. If people who only tried e-cigarettes once or twice are considered not to have used e-cigarettes, the estimated effect was slightly stronger (aOR = 1.98; 95% CI = 1.27-3.10). Also, the estimated odds ratio was higher among vapers who acquired their e-cigarettes from overseas websites (aOR = 2.24; 95% CI = 1.02-4.93).
CONCLUSIONS
Use of e-cigarettes for a smoking cessation attempt appears to be associated with greater success among Australians who attempted to quit tobacco in 2019 compared with Australians attempting to quit without e-cigarettes, after adjusting for confounding effects.

Identifiants

pubmed: 35403757
doi: 10.1111/add.15897
pmc: PMC9545104
doi:

Substances chimiques

Nicotine 6M3C89ZY6R

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2306-2315

Informations de copyright

© 2022 The Author. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction.

Références

BMJ. 2017 Jul 26;358:j3262
pubmed: 28747333
Addiction. 2019 Jun;114(6):1060-1073
pubmed: 30681215
Int J Drug Policy. 2015 Jun;26(6):589-94
pubmed: 25724266
Tob Control. 2022 Aug;31(e1):e66-e73
pubmed: 33753550
Nicotine Tob Res. 2012 Dec;14(12):1483-7
pubmed: 22318689
Nicotine Tob Res. 2017 Nov 01;19(11):1268-1276
pubmed: 28340053
Nicotine Tob Res. 2021 Aug 29;23(10):1699-1707
pubmed: 33837435
Nicotine Tob Res. 2020 Apr 21;22(5):728-733
pubmed: 31298296
Addiction. 2019 Oct;114 Suppl 1:15-23
pubmed: 30701622
BMJ. 2016 Sep 13;354:i4645
pubmed: 27624188
Addiction. 2014 Mar;109(3):491-9
pubmed: 24372901
Addiction. 2019 Sep;114(9):1627-1638
pubmed: 31117151
Addiction. 2014 Sep;109(9):1531-40
pubmed: 24846453
Tob Control. 2018 May;27(3):341-346
pubmed: 28624764
Aust N Z J Public Health. 2001 Dec;25(6):494-7
pubmed: 11824981
Tob Control. 2019 Jan;28(1):42-49
pubmed: 29574448
Health Rep. 2012 Mar;23(1):47-53
pubmed: 22590805
Addiction. 2022 Aug;117(8):2306-2315
pubmed: 35403757
Addict Behav. 2019 Aug;95:6-10
pubmed: 30784874
Cochrane Database Syst Rev. 2021 Apr 29;4:CD010216
pubmed: 33913154
Addiction. 2021 Oct;116(10):2825-2836
pubmed: 33751671
Addiction. 2022 Jan;117(1):224-233
pubmed: 34187081
Am J Public Health. 1994 Jul;84(7):1086-93
pubmed: 8017530

Auteurs

Mark S Chambers (MS)

National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH